All news

Humana trades 10.9% below analyst target of $469.29

Alpha Vantage · MarketBeat · · AI-summarised by FinFlash

Humana Inc. (NYSE:HUM) has an average "Moderate Buy" rating from thirty-two research firms, with an average one-year price target of $469.57. Following strong third-quarter earnings and a raised 2026 adjusted EPS outlook, several brokerages increased their price targets. The company also recently declared a quarterly dividend of $0.8850.

Read original source

HUM company analysis

Understand the context

Published information may change. Summaries can contain errors; check the original source. Educational information only, not investment advice.